SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-005990
Filing Date
2018-01-08
Accepted
2018-01-08 16:33:06
Documents
67
Period of Report
2017-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d508102d10q.htm 10-Q 303754
2 EX-4.5 d508102dex45.htm EX-4.5 55116
3 EX-31.1 d508102dex311.htm EX-31.1 9514
4 EX-31.2 d508102dex312.htm EX-31.2 9519
5 EX-32.1 d508102dex321.htm EX-32.1 4288
6 EX-32.2 d508102dex322.htm EX-32.2 3852
  Complete submission text file 0001193125-18-005990.txt   3903936

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cydy-20171130.xml EX-101.INS 536034
8 XBRL TAXONOMY EXTENSION SCHEMA cydy-20171130.xsd EX-101.SCH 57051
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cydy-20171130_cal.xml EX-101.CAL 50161
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cydy-20171130_def.xml EX-101.DEF 338183
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cydy-20171130_lab.xml EX-101.LAB 415231
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cydy-20171130_pre.xml EX-101.PRE 390291
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 18516807
SIC: 2834 Pharmaceutical Preparations